# Thrombocytopenia in Dogs and Cats: Diagnostic Approach and Differential Prioritization ## Key Takeaways - True thrombocytopenia must be confirmed by blood smear examination to rule out artifactual causes like platelet clumping, which is particularly common in cats and can lead to falsely low automated counts. - The diagnostic approach categorizes thrombocytopenia mechanistically into decreased production, increased destruction, consumption, sequestration, or loss, with immune-mediated destruction and infectious causes being the most frequent in small animals. - Vector-borne diseases such as anaplasmosis and leishmaniasis are critical differentials, especially in endemic regions, and require specific diagnostic testing (e.g., PCR, serology) before initiating immunosuppressive therapy for suspected immune-mediated thrombocytopenia. - Immune-mediated thrombocytopenia (ITP) is a diagnosis of exclusion, and while platelet-bound antibody tests can support the diagnosis, they do not definitively differentiate primary ITP from secondary immune-mediated destruction. - Bone marrow evaluation is indicated for persistent, unresponsive thrombocytopenia, concurrent cytopenias, suspected neoplasia, or when peripheral destruction is not evident, to assess megakaryocyte numbers and rule out primary marrow disease. - Clinical bleeding severity (e.g., melena) and azotemia are significant prognostic indicators in canine immune-mediated thrombocytopenia, necessitating intensified monitoring and prompt management of complications like hemorrhage and thromboembolism. --- Thrombocytopenia is among the most frequently encountered hematologic abnormalities in small animal practice, and its detection often precipitates urgent diagnostic investigation. This article provides a systematic framework for the practicing veterinarian, moving from confirmation of true thrombocytopenia through mechanistic classification to prioritized differential diagnosis in dogs and cats. The focus is diagnostic reasoning, not treatment. The central clinical challenge is that a low platelet count on a hematology analyzer does not confirm a patient is thrombocytopenic. Preanalytical artifacts, particularly platelet clumping, can produce falsely low counts in otherwise normothrombocytopenic animals. Conversely, a genuinely thrombocytopenic patient may present with minimal clinical signs, and the underlying cause may range from a transient, self-limiting process to a life-threatening neoplastic or infectious disease. The diagnostic approach therefore begins with laboratory verification, proceeds through assessment of clinical context and concurrent clinicopathologic abnormalities, and culminates in a prioritized differential list tailored to the individual patient. This article serves veterinarians in general and emergency practice who require a practical, evidence-informed pathway for evaluating thrombocytopenia. It addresses the physiologic basis of platelet production and consumption, the technical factors that confound platelet enumeration, and the major differential categories with their distinguishing features. ## At a Glance | Parameter | Key Decision or Fact | |---|---| | First step | Confirm true thrombocytopenia by blood smear examination before pursuing extensive diagnostics | | Platelet clumping | Most common cause of spurious thrombocytopenia, verify with smear review and consider alternative anticoagulants | | Mechanistic categories | Decreased production, increased destruction, consumption, sequestration, or loss | | Immune-mediated thrombocytopenia | Diagnosis of exclusion, platelet-bound antibody tests support but do not confirm | | Infectious causes | Tick-borne diseases are regionally important, blood smear may reveal organizms in some cases | | Bone marrow evaluation | Indicated when production failure is suspected or when thrombocytopenia is persistent and unexplained | | Prognostic indicators | Clinical bleeding severity and azotemia correlate with outcome in canine immune-mediated thrombocytopenia | ## Physiology of Platelet Homeostasis Platelets are anucleate fragments derived from megakaryocytes in the bone marrow. The circulating platelet mass reflects the balance between production, governed largely by thrombopoietin, and removal, which occurs through senescence, consumption in hemostasis, or immune-mediated clearance. The bone marrow possesses substantial reserve capacity and can increase platelet production several-fold in response to demand. Consequently, thrombocytopenia resulting from peripheral destruction or consumption typically develops over days, whereas thrombocytopenia from marrow failure may evolve more slowly unless the insult is acute and severe. The spleen sequesters a variable proportion of the circulating platelet mass. Splenic sequestration can contribute to mild thrombocytopenia in patients with splenomegaly, though this mechanism rarely produces clinically significant bleeding. Platelet lifespan in dogs and cats is approximately 5 to 7 days, which means that a transient cessation of production must persist for more than a week before the platelet count falls below the reference interval. ## Laboratory Confirmation and Artifacts Automated platelet counts are accurate for most canine and feline blood samples, but preanalytical variables can cause substantial error. Platelet clumping is the most common cause of spurious thrombocytopenia in both species. Clumping occurs when platelets activate during collection or processing, often because of difficult venipuncture, prolonged sample handling, or inadequate mixing with anticoagulant. Feline platelets are particularly prone to clumping, and some cats with normal platelet numbers will have automated counts in the severely thrombocytopenic range. Blood smear examination is the definitive method for verifying automated platelet counts. The smear should be evaluated in the monolayer region, and the platelet count estimated by averaging the number of platelets per high-power field and multiplying by a conversion factor, typically 15,000 to 20,000 platelets per microliter per platelet counted. The presence of clumps on the smear, even in the feathered edge, should prompt caution in interpreting the automated count. When clumping is identified, options include re-collection into a different anticoagulant, such as sodium citrate, or reliance on the estimated count from the smear. The [ASVCP quality assurance and laboratory standards guidance](https://www.asvcp.org/page/QALS_Guidelines) emphasizes that reference intervals and method validation must be considered when interpreting any hematologic result, and this is particularly relevant for platelet enumeration where analyzer methodology varies. Other causes of spurious thrombocytopenia include platelet satellitosis around neutrophils, which is uncommon in dogs and rare in cats, and giant platelets that exceed the analyzer's size threshold for platelet identification. Conversely, red cell fragments or microcytic erythrocytes can be erroneously counted as platelets, producing a falsely normal or elevated count in a patient with true thrombocytopenia. ## Mechanisms of True Thrombocytopenia Once true thrombocytopenia is confirmed, the differential diagnosis is organized by mechanism. The four principal mechanisms are decreased production, increased destruction, consumption, and sequestration or loss. Most clinically significant thrombocytopenia in dogs and cats results from increased destruction or consumption, with immune-mediated thrombocytopenia and infectious disease being the leading causes in most regions. Decreased production arises from bone marrow disorders including primary hematologic malignancies, myelofibrosis, drug-induced suppression, and infectious agents that infect hematopoietic precursors. The [consensus classification of acute myeloid leukemia in dogs and cats](https://pubmed.ncbi.nlm.nih.gov/12673541/) provides a framework for recognizing neoplastic marrow infiltration as a cause of thrombocytopenia, and emphasizes that circulating blast cells may be absent in some cases, making marrow evaluation essential for diagnosis. Increased destruction is most commonly immune-mediated, either primary or secondary to infection, neoplasia, or drug exposure. Consumption occurs through disseminated intravascular coagulation, vasculitis, or severe hemorrhage. Sequestration in an enlarged spleen and loss through acute hemorrhage are less common causes of marked thrombocytopenia, though hemorrhage can produce moderate decreases when blood loss is substantial and rapid. ## Diagnostic Sequence for Thrombocytopenia The diagnostic approach to thrombocytopenia proceeds through three defined stages: confirmation of the true platelet deficit, assessment of clinical context, and prioritization of differential diagnoses. Each stage has explicit decision points that redirect the investigation. ### Step 1: Confirm the Platelet Count Before any diagnostic reasoning begins, the platelet count must be verified as accurate. Automated impedance counters report low platelet numbers when clumps are present, when platelets are large enough to be counted as erythrocytes, or when the sample was collected improperly. The blood smear remains the reference method for confirmation. Examine the monolayer region at 1000x magnification and estimate platelet numbers per field. A count of 8 to 15 platelets per oil immersion field approximates a normal count of 200,000 to 300,000 platelets per microliter, though this estimate varies with the smear thickness and the species. Platelet clumping is the most common cause of spurious thrombocytopenia in both dogs and cats. Feline platelets are particularly prone to aggregation. When clumps are present, the automated count is unreliable and the smear estimate becomes the working value. If the smear shows adequate platelet numbers despite a low automated count, the thrombocytopenia is artifactual and no further investigation is warranted. Repeat collection into a new tube with careful venipuncture technique may be offered, but the smear estimate is sufficient to resolve the question in most cases. ### Step 2: Assess Clinical Context Once true thrombocytopenia is confirmed, the clinical presentation determines the pace and direction of the workup. Three patterns emerge: - **Bleeding patient**: Pets with petechiae, ecchymoses, mucosal hemorrhage, or bleeding from venipuncture sites require immediate assessment of hemostasis. The platelet count is usually below 30,000 per microliter before spontaneous bleeding occurs, but individual variation exists. - **Febrile or systemically ill patient**: Fever, lethargy, and inappetence in a thrombocytopenic dog or cat suggest an infectious or inflammatory cause. Vector-borne disease, sepsis, and rickettsial infection are leading considerations. - **Incidental finding**: An asymptomatic patient with mild to moderate thrombocytopenia discovered on routine blood work presents a different challenge. The differential list is broader and the diagnostic pace is slower. The history should include tick exposure, travel history, vaccination status, current medications, and any prior episodes of bleeding or bruising. The physical examination should evaluate mucous membranes, skin, lymph nodes, spleen, and joints. The presence of splenomegaly, lymphadenopathy, or fever narrows the differential list substantially. ### Step 3: Rank the Differential Diagnoses The mechanisms of thrombocytopenia established in the previous section provide the framework for prioritization. In clinical practice, the most common causes in dogs and cats are, in approximate order of frequency: | Rank | Cause | Key Features | Diagnostic Test | |------|-------|--------------|-----------------| | 1 | Platelet consumption (immune-mediated or infectious) | Acute onset, bleeding, fever, tick exposure | Blood smear, infectious disease serology/PCR, platelet-bound antibody testing | | 2 | Platelet destruction (immune-mediated) | Young to middle-aged dog, bleeding, no fever | Rule out infection first, then consider primary ITP | | 3 | Sequestration | Splenomegaly, chronic disease | Abdominal ultrasound, underlying disease workup | | 4 | Decreased production | Chronic course, pancytopenia, nonregenerative anemia | Bone marrow aspirate or biopsy | | 5 | Dilution or loss | Recent hemorrhage, fluid therapy | History, serial monitoring | This ranking is a starting point, not a destination. The clinical context modifies it substantially. ## Infectious Causes and Their Recognition Vector-borne infections are a leading cause of thrombocytopenia in dogs and should be investigated before a diagnosis of primary immune-mediated thrombocytopenia is made. The geographic region and tick exposure history determine which agents are most likely. ### Anaplasmosis Canine granulocytic anaplasmosis, caused by *Anaplasma phagocytophilum*, produces acute thrombocytopenia in affected dogs. In a prospective study of 18 naturally infected dogs, all were acutely ill with lethargy, inappetence, and fever, and thrombocytopenia was a consistent laboratory finding. Notably, 6 of 10 dogs tested had a positive platelet-bound antibody test, indicating that the immune response to infection can mimic primary immune-mediated thrombocytopenia. This finding has direct clinical relevance: a positive platelet-bound antibody test does not distinguish infectious from primary ITP, and infectious disease testing should precede immunosuppressive therapy in endemic areas. Morulae within neutrophils are visible on blood smear in some cases, but their absence does not exclude infection. ### Tick-Borne Relapsing Fever Tick-borne relapsing fever, caused by *Borrelia turicatae* and *Borrelia hermsii*, is an underrecognized cause of thrombocytopenia in dogs. In a case series of five naturally infected dogs from Texas, all presented with lethargy, inappetence, and pyrexia, and all had thrombocytopenia. The hallmark diagnostic feature is the visualization of numerous spirochetes on standard blood smear examination. This diagnosis should be considered in endemic areas when a febrile thrombocytopenic dog has no other identifiable cause. The blood smear is rapid and specific when positive. ### Leishmaniasis Canine leishmaniasis is an important cause of thrombocytopenia in endemic regions and in dogs with travel history to those regions. The thrombocytopenia is typically part of a broader clinicopathologic pattern that includes nonregenerative anemia, hyperglobulinemia, and renal dysfunction. Diagnosis may be achieved by cytologic identification of amastigotes in lymph node aspirates, bone marrow samples, or skin lesions, or by PCR on affected tissues. ### Sepsis and Endotoxemia Systemic inflammation consumes platelets through activation and microthrombus formation. In an experimental canine model of endotoxemia, platelet count decreased by a mean of 73% within hours of endotoxin administration. The thrombocytopenia of sepsis is typically accompanied by fever, leukogram changes, and evidence of organ dysfunction. Blood culture and identification of the underlying infectious source are the diagnostic priorities. ## Immune-Mediated Thrombocytopenia Primary immune-mediated thrombocytopenia (ITP) is a diagnosis of exclusion. It is more common in dogs than cats and shows a breed predisposition in Cocker Spaniels. The median age at diagnosis in one retrospective study of 73 dogs was 8.1 years. The presence of melena or an elevated BUN at admission was associated with decreased survival, indicating that the severity of bleeding at presentation carries prognostic significance. The diagnostic workup for suspected ITP includes: 1. Complete blood count with smear review to confirm thrombocytopenia and assess other cell lines 2. Infectious disease testing appropriate to the geographic region, including *Anaplasma*, *Ehrlichia*, *Borrelia*, and *Leishmania* where relevant 3. Biochemistry panel and urinalysis to assess organ function and identify concurrent disease 4. Platelet-bound antibody testing, recognizing that a positive result supports but does not confirm ITP 5. Bone marrow evaluation if the platelet count does not respond to therapy or if other cytopenias are present The decision to begin immunosuppressive therapy requires reasonable confidence that infectious causes have been excluded. In endemic areas, this may mean waiting for PCR results before starting glucocorticoids. The risk of delaying therapy must be weighed against the risk of immunosuppressing a dog with an undiagnosed infectious disease. ## Bone Marrow Evaluation Bone marrow aspiration or biopsy is indicated when: - The thrombocytopenia is chronic and unresponsive to therapy - Other cytopenias are present, suggesting generalized marrow disease - The platelet count is severely depressed with no evidence of peripheral destruction - Neoplasia is suspected The bone marrow sample provides information about megakaryocyte number and morphology. Increased megakaryocytes indicate peripheral consumption or destruction. Decreased megakaryocytes indicate reduced production, which may result from drug toxicity, infectious agents, or primary marrow disease. Acute myeloid leukemia and myelodysplastic syndrome are important differentials when multiple cell lines are affected, and classification schemes for these disorders in dogs and cats have been proposed by veterinary clinical pathologists. ## Documentation and Monitoring The medical record should document the platelet count, the method of confirmation, the smear estimate, and the presence or absence of clumping. Serial platelet counts are essential for monitoring response to therapy and for detecting relapse. In dogs with ITP, relapse occurred in 9% of dogs in one study, supporting the need for ongoing monitoring after discharge. Monitoring parameters include: - Platelet count every 24 to 48 hours during initial therapy - Clinical assessment for bleeding signs at each recheck - Packed cell volume to detect blood loss anemia - Renal parameters in dogs with evidence of bleeding at presentation The frequency of monitoring depends on the severity of thrombocytopenia and the clinical course. A dog with severe bleeding requires daily monitoring. A dog with mild, stable thrombocytopenia may be monitored weekly. The platelet count should be interpreted in the context of the clinical picture, as a rising count with resolving clinical signs is more meaningful than a single value. Species differences affect the approach. Cats with thrombocytopenia are more likely to have infectious or neoplastic causes than primary ITP, and the diagnostic workup should reflect this. Cats also present a greater challenge with platelet clumping, making smear confirmation particularly important. Production animals and exotic species may have different endemic diseases and different practical constraints on diagnostic testing, and the approach should be adjusted accordingly. ## Recognized Complications and Early Detection Thrombocytopenia itself rarely kills, the complications it enables do. Hemorrhage is the most immediate threat, but the underlying disease process often produces morbidity that exceeds the bleeding risk. In dogs with immune-mediated thrombocytopenia, the presence of melena or an elevated blood urea nitrogen concentration at admission correlates with decreased survival probability, so these findings should escalate monitoring intensity from the outset [Treatment and predictors of outcome in dogs with immune-mediated thrombocytopenia](https://pubmed.ncbi.nlm.nih.gov/21281218/). **Hemorrhage.** Severe thrombocytopenia, generally below 30,000 platelets per microlitre, can produce petechiation, ecchymoses, epistaxis, gingival bleeding, or melena. Intracranial or pulmonary hemorrhage is the catastrophic endpoint. Detect early by tracking serial platelet counts, examining mucous membranes at every assessment, and measuring packed cell volume frequently. A falling packed cell volume with stable or improving platelet numbers suggests ongoing blood loss instead of continued destruction. **Thromboembolism.** Paradoxically, immune-mediated thrombocytopenia predisposes to arterial and venous thrombosis. The same immune dysregulation that destroys platelets activates coagulation. Clinical signs depend on the vascular bed affected: acute blindness suggests ocular thrombosis, pelvic limb paresis suggests aortic thromboembolism, and tachypnoea with hypoxemia suggests pulmonary thromboembolism. Maintain a low threshold for diagnostic imaging in any thrombocytopenic patient with unexplained deterioration. **Sepsis.** Thrombocytopenia is both a marker and a consequence of bacterial infection. In a canine endotoxaemia model, platelet count and plateletcrit decreased by a mean of 73% and 93% respectively within hours of endotoxin administration, demonstrating how rapidly infection can consume platelets [Evaluation of platelet count and its association with plateletcrit, mean platelet volume, and platelet size distribution width in a canine model of endotoxemia](https://pubmed.ncbi.nlm.nih.gov/18533914/). Detect early by monitoring temperature, perfusion parameters, and serial blood cultures in febrile thrombocytopenic patients. **Disease-specific progression.** Tick-borne relapsing fever causes thrombocytopenia with spirochetemia, and affected dogs may develop neurologic signs [Tick-Borne Relapsing Fever in Dogs](https://pubmed.ncbi.nlm.nih.gov/27353196/). Canine leishmaniasis produces thrombocytopenia alongside anemia and renal dysfunction, so monitor renal parameters in endemic regions [Laboratory tests for diagnosing and monitoring canine leishmaniasis](https://pubmed.ncbi.nlm.nih.gov/27805725/). Granulocytic anaplasmosis can cause splenomegaly and fever, with morulae visible in neutrophils in a subset of cases [Clinical features of canine granulocytic anaplasmosis in 18 naturally infected dogs](https://pubmed.ncbi.nlm.nih.gov/18783353/). ## Common Diagnostic Errors and Corrections | Observation | Likely error | Discriminating check | |---|---|---| | Low platelet count with no clinical bleeding | Platelet clumping artifact accepted as true thrombocytopenia | Examine blood smear feather edge, request citrated sample or manual count | | Thrombocytopenia attributed to immune destruction without infectious disease testing | Missed vector-borne or bacterial cause | PCR or serology for regionally relevant pathogens before immunosuppression | | Single low count treated as definitive | Failure to repeat and confirm | Repeat CBC within 12 to 24 hours, assess trend instead of absolute value | | Normal platelet count on one analyzer accepted despite clinical bleeding | Analyzer method error or EDTA-induced clumping | Manual count on fresh smear, correlate with clinical signs | | Bone marrow biopsy deferred because patient is unstable | Delayed diagnosis of marrow failure or leukemia | Aspirate cytology is rapid and can be performed with minimal sedation | Less experienced clinicians commonly overinterpret a single low platelet count, particularly when the patient is otherwise stable. The corrective action is to repeat the count, examine the smear personally, and integrate the result with the physical examination. Another frequent error is initiating glucocorticoid therapy before excluding infectious causes. In regions where anaplasmosis, ehrlichiosis, or leishmaniasis are endemic, this can worsen the underlying infection. The platelet-bound antibody test can be positive in granulocytic anaplasmosis, so a positive result does not by itself confirm primary immune-mediated thrombocytopenia [Clinical features of canine granulocytic anaplasmosis in 18 naturally infected dogs](https://pubmed.ncbi.nlm.nih.gov/18783353/). ## Evidence Limitations and Areas of Expert Dispute The evidence base for thrombocytopenia in dogs and cats is uneven. Acute myeloid leukemia classification in dogs and cats was adapted from human criteria in the early 1990s, with diagnostic concordance among pathologists ranging from 60% to 81% and interobserver agreement from 51% to 85% [Proposed criteria for classification of acute myeloid leukemia in dogs and cats](https://pubmed.ncbi.nlm.nih.gov/12673541/). This means that even experienced pathologists disagree on leukemia subtype in a substantial minority of cases, and clinicians should expect some diagnostic uncertainty. The duration of spirochetemia in tick-borne relapsing fever has not been fully characterized in dogs, so negative blood smears between febrile episodes do not exclude the diagnosis [Tick-Borne Relapsing Fever in Dogs](https://pubmed.ncbi.nlm.nih.gov/27353196/). Similarly, the clinical significance of platelet indices such as mean platelet volume and platelet distribution width remains uncertain, although they may reflect changes in platelet production and reactivity [Evaluation of platelet count and its association with plateletcrit, mean platelet volume, and platelet size distribution width in a canine model of endotoxemia](https://pubmed.ncbi.nlm.nih.gov/18533914/). Expert opinion differs on the threshold for bone marrow aspiration in suspected immune-mediated thrombocytopenia. Some clinicians aspirate early to exclude primary marrow disease, others reserve it for cases that fail to respond to immunosuppression. Both approaches are defensible, but the decision should be documented and revisited if the platelet count does not improve within the expected timeframe. ## Referral, Consultation, and Reporting Referral to a specialist is warranted when thrombocytopenia persists despite appropriate treatment, when the platelet count falls below 10,000 per microlitre with active bleeding, when bone marrow evaluation is needed but unavailable, or when the clinical picture suggests a hematologic malignancy. Veterinary clinical pathologists can review blood smears and bone marrow preparations when local expertise is limited. Diagnostic laboratories can perform specialised testing including platelet antibody assays, flow cytometry, and molecular assays for infectious agents. Regulatory reporting obligations vary by jurisdiction and disease. Reportable diseases that may cause thrombocytopenia include certain vector-borne infections and zoonotic agents. The World Organization for Animal Health maintains international standards for disease surveillance and reporting, and national veterinary authorities determine which diseases are notifiable within their territory [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/). Clinicians should consult their regional veterinary authority or professional body for current requirements [AVMA practice resources](https://www.avma.org/resources-tools). When a zoonotic disease such as leishmaniasis is diagnosed, client education about human exposure risk is appropriate, and public health authorities may need notification in some regions. ## Frequently Asked Questions ### How should I proceed when an in-house analyzer reports a low platelet count but I cannot verify it with a blood smear? If a blood smear cannot be prepared or examined, repeat the count using a different method if available, such as impedance on a second analyzer or optical fluorescence counting. Platelet clumping is the most common cause of spurious thrombocytopenia, and the risk is highest with EDTA samples from cats. If the clinical picture does not match severe thrombocytopenia, treat the count as unconfirmed. Consider re-collecting blood into citrate or heparin for a comparative count, though each anticoagulant has its own artifacts. When no alternative exists, interpret the low count cautiously and pair it with clinical signs, mucosal bleeding, and response to therapy. The [ASVCP quality assurance guidelines](https://www.asvcp.org/page/QALS_Guidelines) address method validation and sample handling expectations for practice laboratories. ### What is the minimum database I should obtain before starting immunosuppressive therapy for suspected immune-mediated thrombocytopenia? A minimum database includes a CBC with manual smear review, serum biochemistry, urinalysis, and vector-borne disease testing appropriate for your region. Thoracic radiographs and abdominal ultrasound are indicated when neoplasia or sepsis is suspected. In endemic areas, test for Anaplasma, Ehrlichia, Babesia, and Leishmania before committing to immunosuppression, because glucocorticoids can worsen some infections. Platelet-bound antibody testing is not widely available and does not reliably distinguish primary from secondary immune-mediated disease. The retrospective data from [O'Marra et al. on treatment and predictors of outcome in dogs with immune-mediated thrombocytopenia](https://pubmed.ncbi.nlm.nih.gov/21281218/) show that melena and elevated BUN at admission predict poorer survival, so document these findings explicitly. ### How do I distinguish thrombocytopenia from hemodilution or sample degradation in a sick patient? Hemodilution lowers all cell lines proportionally, so a low platelet count with normal hematocrit and leukocyte count argues against dilution. Sample degradation from prolonged storage or overheating produces platelet swelling and fragmentation that analyzers may misclassify. Compare platelet indices such as mean platelet volume and platelet distribution width, marked variation suggests fragmentation instead of true thrombocytopenia. In endotoxemia, platelet count and plateletcrit fall together while mean platelet volume changes, as shown in the [canine endotoxemia model by Yilmaz et al.](https://pubmed.ncbi.nlm.nih.gov/18533914/). Re-collect a fresh sample into a properly filled EDTA tube and examine the smear within two hours. If the repeat count is normal, the original result was artifact. ### What should I tell a client whose dog has thrombocytopenia and a positive tick-borne disease test? Explain that the test result identifies exposure or active infection, and that thrombocytopenia in this context is most likely caused by the infection itself. For example, dogs with granulocytic anaplasmosis are frequently thrombocytopenic, and some also have platelet-bound antibodies, as described in [Kohn et al. on clinical features of canine granulocytic anaplasmosis](https://pubmed.ncbi.nlm.nih.gov/18783353/). Reassure the client that appropriate antimicrobial therapy usually resolves the thrombocytopenia, but warn that co-infections are possible and that a single positive test does not exclude other causes. Advise that repeat testing after treatment confirms clearance. If the platelet count does not improve within the expected interval, reassess for immune-mediated disease, bone marrow suppression, or a second pathogen. ### When is bone marrow aspiration indicated in a thrombocytopenic patient? Bone marrow evaluation is indicated when peripheral destruction is unlikely, when the patient is pancytopenic, when there is no response to appropriate therapy, or when neoplasia is suspected. It is also useful when infectious causes have been excluded and the thrombocytopenia persists beyond the expected recovery period. Cytology can identify megakaryocytic hypoplasia, maturation arrest, or infiltrative disease. The classification of acute myeloid leukemia relies on bone marrow blast percentages and cytomorphology, as outlined in the [proposed criteria for acute myeloid leukemia classification in dogs and cats by Jain et al.](https://pubmed.ncbi.nlm.nih.gov/12673541/). In a stable patient with isolated thrombocytopenia and normal other cell lines, bone marrow examination can often be deferred until response to therapy is assessed. ### How should I document serial platelet counts and communicate trends to a referring veterinarian? Record the platelet count, analyzer method, and whether a smear was reviewed for each sample. Note the presence or absence of clumps, the estimated count from the smear, and any platelet indices. Serial counts should be compared using the same method whenever possible, because impedance and optical methods can differ. In the medical record, state the suspected mechanism, the differential list, and the response to each intervention. When communicating with a referring veterinarian, provide the trend instead of a single value, and specify whether the count is improving, stable, or declining. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) offers species-specific reference intervals that can guide interpretation when local intervals are unavailable. ## Related Clinical & Scientific Guides * [Peripheral Blood Smear Evaluation: A Step-by-Step Guide](/knowledge/veterinary-medicine/clinical-pathology/peripheral-blood-smear-evaluation-guide) * [Reticulocyte Counts in Veterinary Medicine: Clinical Utility and Interpretation](/knowledge/veterinary-medicine/clinical-pathology/reticulocyte-counts-veterinary-medicine) * [Cerebrospinal Fluid Analysis in Veterinary Neurology: Collection and Interpretation](/knowledge/veterinary-medicine/clinical-pathology/cerebrospinal-fluid-analysis-veterinary) ## References and Further Reading - [Tick-Borne Relapsing Fever in Dogs.](https://pubmed.ncbi.nlm.nih.gov/27353196/). 2016. - [Laboratory tests for diagnosing and monitoring canine leishmaniasis.](https://pubmed.ncbi.nlm.nih.gov/27805725/). 2016. - [Proposed criteria for classification of acute myeloid leukemia in dogs and cats.](https://pubmed.ncbi.nlm.nih.gov/12673541/). 1991. - [Treatment and predictors of outcome in dogs with immune-mediated thrombocytopenia.](https://pubmed.ncbi.nlm.nih.gov/21281218/). 2011. - [Evaluation of platelet count and its association with plateletcrit, mean platelet volume, and platelet size distribution width in a canine model of endotoxemia.](https://pubmed.ncbi.nlm.nih.gov/18533914/). 2008. - [Clinical features of canine granulocytic anaplasmosis in 18 naturally infected dogs.](https://pubmed.ncbi.nlm.nih.gov/18783353/). 2008. - [American Society for Veterinary Clinical Pathology Guidelines](https://www.asvcp.org/page/QALS_Guidelines). American Society for Veterinary Clinical Pathology. - [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual. - [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association. ## Related Articles - [Proteinuria in Dogs and Cats: Diagnostic Approach and Clinical Significance](/knowledge/veterinary-medicine/clinical-pathology/proteinuria-dogs-cats-diagnostic) - [Leukogram Patterns in Dogs and Cats: A Diagnostic Guide](/knowledge/veterinary-medicine/clinical-pathology/leukogram-patterns-dogs-cats) - [Interpreting the Canine CBC: A Diagnostic Approach](/knowledge/veterinary-medicine/clinical-pathology/interpreting-canine-cbc-diagnostic-approach) - [Monitoring Effusion Recurrence and Management in Dogs and Cats](/knowledge/veterinary-medicine/clinical-pathology/monitoring-effusion-recurrence-management-dogs-cats) - [Cytology of Lymph Nodes: Diagnostic Approach to Lymphadenopathy](/knowledge/veterinary-medicine/clinical-pathology/cytology-lymph-nodes-diagnostic) > This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.